$CPBBearishLow

Top analysts reset Campbell’s stock amid major challenges

Between June 1-5, five Wall Street analysts adjusted Campbell’s (CPB) outlook ahead of its June 8 Q3 fiscal 2026 results, according to Benzinga. Targets were cut by Morgan Stanley ($21 from $23), Bernstein ($19 from $21, downgraded to underperform), UBS ($19 from $20), and Evercore ISI ($24 from $26). Campbell reported adjusted EPS of 50 cents (+1 penny YoY, -32%), net sales down 4% to $2.4B, and margin pressure from tariffs; snacks margins fell ~400 bps.

7/10
4/10
Low
Bearish
after June 8 earnings; analyst target resets reported June 1–5
bearish—target cuts align with weaker sales/margins and management’s tariff-cost outlook

Analyst target cuts and the earnings margin/tariff details reinforce a near-term earnings risk skew toward snacks weakness and tariff-driven costs.

Campbell’s earnings showed adjusted EPS down 32% and net sales down 4%, with tariffs adding 310 bps cost pressure.

Near-term downside/underperformance risk versus defensive peers until snacks margins stabilize and tariff inflation eases.

Background

Campbell’s is typically treated as a defensive packaged-food name due to recession-resilient demand for soups and snacks.

Why it matters

The article links analyst target reductions to the June 8 earnings details: weaker net sales, contracting gross margin, and explicit tariff-driven cost pressure, with snacks identified as the weakest segment.

Market relevance

Traders should focus on whether snacks margins stabilize and whether tariff/input-cost inflation eases, since these are the concrete drivers cited for the analyst resets.

Market effects

Reinforces that even defensive food names can face margin compression from tariffs/input-cost inflation, shifting focus to segment-level profitability (snacks vs soups).

Primarily US demand and tariff/input-cost dynamics (U.S. soup consumption down 4.4%).

Tariff and supply-chain cost pressures are framed as persistent into next fiscal year, potentially affecting broader packaged-food cost structures.

Alternative perspectives

The company reaffirmed full-year fiscal 2026 guidance and premium Rao’s consumption grew 15%, suggesting some demand resilience that could limit downside if costs normalize.

Dividend yield is elevated (~7.3%) and management prioritizes debt reduction; if tariff costs absorb/decline faster than expected, the market may re-rate the stock despite near-term snacks weakness.

Key entities

  • Campbell’s

    CPB; earnings showed declining sales and margins, with tariffs adding 310 bps cost pressure and snacks margins still under pressure.

Related articles

$CPBMedAI 8/10

Campbell's Q3 Earnings Call Highlights

Campbell’s executives said incentive compensation reset and higher marketing are expected to add about a $40 million impact next year, while the company plans to accelerate savings from a previously announced $100 million SG&A reduction and other productivity initiatives. Snacks margins improved sequentially (EBITDA margin ~7% to ~10%) but remain ~400 bps below last year. Q4 net sales are expected flat to slightly up; adjusted EPS likely around $2.20 or below.

$MRVLMed

Index rebalancing can deliver bargains. Here’s how to find them

S&P 500 index managers announced quarterly changes: Marvell Technology and Flex Ltd. will join the index, while Pool Corp. and Campbell’s Co. will be removed. The article says added stocks have averaged about +255% over the past year versus -36% for deletions. It cites Research Affiliates’ 2024 paper: deletions outperformed by over 5% annually over the next five years.

$MUMed

ASX set to rise, Wall Street steadies as tech stocks rebound

Wall Street steadied after last week’s sell-off, with the S&P 500 up 0.3% (Nasdaq +0.9%, Dow -0.2%). AI-linked chip and memory stocks rebounded: Micron rose 9.9% after a 13.3% Friday drop; Marvell gained 9.6% after being approved for the S&P 500. ASX futures pointed to a 0.3% open gain. Oil rose on Israel-Iran strikes, with Brent settling at $94.25 (+1.2%).

$MUMed

ASX set to rise, Wall Street steadies as tech stocks rebound

Wall Street steadied after last week’s sell-off as AI-linked tech rebounded. The S&P 500 rose 0.3% (after a 2.6% Friday drop); Nasdaq gained 0.9%. ASX futures pointed to a 0.3% rise. Micron jumped 9.9% after a 13.3% Friday fall; Marvell rose 9.6% after S&P Dow Jones said it would join the S&P 500. Oil firmed on Israel-Iran strikes; Brent settled at $94.25 (+1.2%).

$CPBMedAI 8/10

Campbells’ Out with Q3 Figures

Campbell’s (NASDAQ:CPB) reported Q3 FY2026 results for the quarter ended May 3. Net sales fell 4% to $2.4B; organic sales also down 4% on lower volume/mix, offset by net price gains. Gross profit dropped 11% to $650M and margin to 27.5%. Adjusted EBIT fell 24% to $274M. CEO said results were in line but under pressure.